The Leukemia Atlas: Researchers unveil proteins that signal disease
Wednesday, April 17, 2019 - 08:40
in Health & Medicine
Only about one in four people diagnosed with acute myelogenous leukemia (AML) survive five years after the initial diagnosis. To improve that survival rate, researchers have created an online atlas to identify and classify protein signatures present at AML diagnosis.